{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:10:43Z","timestamp":1778811043133,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2023\/11479-7"],"award-info":[{"award-number":["2023\/11479-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2019\/25119-7"],"award-info":[{"award-number":["2019\/25119-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"FIOCRUZ","doi-asserted-by":"publisher","award":["VPPCB-007-18-2-134"],"award-info":[{"award-number":["VPPCB-007-18-2-134"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"FIOCRUZ","doi-asserted-by":"publisher","award":["VPPCB-005-FIO-20-2-87"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-87"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"FIOCRUZ","doi-asserted-by":"publisher","award":["VPGDI-050-FIO-20-2-13-36"],"award-info":[{"award-number":["VPGDI-050-FIO-20-2-13-36"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"FACEPE","doi-asserted-by":"publisher","award":["IBPG-0549-2-10\/22"],"award-info":[{"award-number":["IBPG-0549-2-10\/22"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"FACEPE","doi-asserted-by":"publisher","award":["BFP-0010-2.11\/22"],"award-info":[{"award-number":["BFP-0010-2.11\/22"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"FACEPE","doi-asserted-by":"publisher","award":["APQ-0346-2-09-19"],"award-info":[{"award-number":["APQ-0346-2-09-19"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012416","name":"Inova Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["307209\/2023-7"],"award-info":[{"award-number":["307209\/2023-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["304476\/2022-6"],"award-info":[{"award-number":["304476\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["425997\/2018-9"],"award-info":[{"award-number":["425997\/2018-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["165071\/2018-4"],"award-info":[{"award-number":["165071\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["310184\/2023-1"],"award-info":[{"award-number":["310184\/2023-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["303833\/2022-0"],"award-info":[{"award-number":["303833\/2022-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcv.2025.105880","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:49:36Z","timestamp":1760140176000},"page":"105880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serological analysis of COVID-19 patients highlights cross-reactivity of antibodies with the HIV-1 2F5 epitope"],"prefix":"10.1016","volume":"181","author":[{"given":"Tayn\u00e1 E.","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.A.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.V.G.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Dhalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciane M.E.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria N.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel L.","family":"Wallau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto D.","family":"Lins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-6635","authenticated-orcid":false,"given":"Isabelle F.T.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2025.105880_bib1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/QAD.0000000000002904","article-title":"False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection","volume":"35","author":"Papamanoli","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2025.105880_bib2","article-title":"False-positive HIV in a patient with SARS-CoV-2 infection; A case report","volume":"71","author":"Salih","year":"2021","journal-title":"Ann. Med. Surg. (Lond. )"},{"key":"10.1016\/j.jcv.2025.105880_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/jclinpath-2020-206942","article-title":"Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results","volume":"74","author":"Tan","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2025.105880_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0000000000003507","article-title":"Increased risk of false-positive HIV ELISA results after COVID-19","volume":"37","author":"Alfie","year":"2023","journal-title":"Aids"},{"key":"10.1016\/j.jcv.2025.105880_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciad264","article-title":"Increase in False-Positive Fourth-Generation human immunodeficiency virus tests in patients with coronavirus disease 2019","volume":"77","author":"Gudipati","year":"2023","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jcv.2025.105880_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/jgid.jgid_226_21","article-title":"False-Positive human immunodeficiency virus reactivity in COVID patients: a word of caution","volume":"14","author":"Srivastava","year":"2022","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105880_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jclinpath-2021-207813","article-title":"Letter to the editor: additional evidence to support a cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay","volume":"75","author":"Cipitelli","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2025.105880_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/AOG.0000000000005254","article-title":"False-Positive human immunodeficiency virus screening results in pregnancy during the coronavirus disease 2019 (COVID-19) pandemic","volume":"142","author":"Miller","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2025.105880_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2180-3-20","article-title":"Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy","volume":"3","author":"Kliger","year":"2003","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.jcv.2025.105880_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jcv.2025.105880_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/096876899294706","article-title":"Structural basis for membrane fusion by enveloped viruses","volume":"16","author":"Weissenhorn","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.jcv.2025.105880_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71748-7","article-title":"Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition","volume":"10","author":"Grant","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2025.105880_bib13","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcv.2025.105880_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108187","article-title":"The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with human immunodeficiency virus (HIV-1) gp41","volume":"101","author":"Perween","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jcv.2025.105880_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009958","article-title":"Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma","volume":"17","author":"Mishra","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2025.105880_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.theochem.2004.02.018","article-title":"Structural similarity between HIV-1 gp41 and SARS-CoV S2 proteins suggests an analogous membrane fusion mechanism","volume":"677","author":"Wu Zhang","year":"2004","journal-title":"Theochem"},{"key":"10.1016\/j.jcv.2025.105880_bib17","article-title":"Model of the pre-insertion region of the spike (S2) fusion glycoprotein of the human SARS coronavirus: implications for antiviral therapeutics","volume":"2","author":"Gallaher","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2025.105880_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jiad544","article-title":"SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and nef antibodies in men with HIV-1","volume":"229","author":"Tuttle","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105880_bib19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1017\/S0950268818001218","article-title":"Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection","volume":"146","author":"Viana","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.jcv.2025.105880_bib20","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1039\/c3ra41562g","article-title":"De novo design of immunoreactive conformation-specific HIV-1 epitopes based on Top7 scaffold","volume":"3","author":"Viana","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.jcv.2025.105880_bib21","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","author":"Amanat","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jcv.2025.105880_bib22","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e3548","article-title":"SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients","volume":"76","author":"Silva","year":"2021","journal-title":"Clinics"},{"key":"10.1016\/j.jcv.2025.105880_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2010.12.008","article-title":"Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mab 2F5","volume":"136","author":"Palacios-Rodriguez","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jcv.2025.105880_bib24","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1074\/jbc.M113.527747","article-title":"Structure and immunogenicity of a peptide vaccine, including the complete HIV-1 gp41 2F5 epitope: implications for antibody recognition mechanism and immunogen design","volume":"289","author":"Serrano","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jcv.2025.105880_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2017.07.007","article-title":"Neutralizing antibodies against a specific human immunodeficiency virus gp41 epitope are associated with Long-term Non-progressor status","volume":"22","author":"Lucar","year":"2017","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jcv.2025.105880_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117088","article-title":"Cross-reactivity mediated by SARS-CoV-2 antibodies: mechanism and impact of elevated HIV ELISA false-positive rates in the late-phase COVID-19 pandemic","volume":"114","author":"Wang","year":"2026","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105880_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00126334-200204010-00005","article-title":"Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation","volume":"29","author":"Calabrese","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2025.105880_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v15051161","article-title":"False-Positive screening and confirmatory HIV diagnostic test in a patient with cured SARS-CoV-2 infection is not mediated by Env\/Spike Cross-Reactive antibodies","volume":"15","author":"Elsner","year":"2023","journal-title":"Viruses"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:54:06Z","timestamp":1778810046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S1386653225001222"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105880","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological analysis of COVID-19 patients highlights cross-reactivity of antibodies with the HIV-1 2F5 epitope","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105880"}}